Clinical Trial Update: Adipokines and the Risk of Reflux Esophagitis

View source ↗

Summary

Clinical trial update examining the association between adipokines and the risk of reflux esophagitis in individuals with visceral obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Reflux Esophagitis

Snippet

Sponsor: Seoul National University Hospital | Conditions: Visceral Obesity, Reflux Esophagitis | Status: UNKNOWN